Cargando…
Tacrolimus-Induced Type IV Renal Tubular Acidosis following Liver Transplantation
Calcineurin inhibitors remain an integral component of immunosuppressive therapy regimens following solid organ transplantation. Although nephrotoxicity associated with these agents is well documented, type IV renal tubular acidosis is a rare and potentially underreported complication following live...
Autores principales: | Schmoyer, Christopher, Mishra, Suraj, Fulco, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518501/ https://www.ncbi.nlm.nih.gov/pubmed/28761769 http://dx.doi.org/10.1155/2017/9312481 |
Ejemplares similares
-
Type 3 renal tubular acidosis
por: Goswami, R. P., et al.
Publicado: (2012) -
Flecainide toxicity in renal tubular acidosis type IV treated with extracorporeal membrane oxygenation
por: Bhimani, Salima Ahmed, et al.
Publicado: (2020) -
Type 4 renal tubular acidosis in a kidney transplant recipient
por: Kulkarni, Manjunath
Publicado: (2016) -
Acid–Base Imbalance in Pseudohypoaldosteronism Type 1 in Comparison With Type IV Renal Tubular Acidosis
por: Adachi, Masanori, et al.
Publicado: (2022) -
Calcineurin Inhibitor-Induced Type IV Renal Tubular Acidosis in Post-Bone Marrow Transplant: Review of Pathophysiology and Principles of Management
por: AL-Omairi, Anwar, et al.
Publicado: (2023)